# A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients

> **NCT02035020** · PHASE2 · COMPLETED · sponsor: **Azienda Policlinico Umberto I** · enrollment: 10 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** gamma interferon

## Key facts

- **NCT ID:** NCT02035020
- **Lead sponsor:** Azienda Policlinico Umberto I
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-07-30
- **Final completion:** 2014-07-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02035020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02035020, "A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02035020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*